Literature DB >> 28135860

Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes.

Supriya Vishwakarma1, Rahul Agarwal2, Sudhir K Goel1, Rajendra K Panday3, Renu Singh2, Ravi Sukumaran2, Sarita Khare4, Ashok Kumar1.   

Abstract

We have determined the gene expression of sphingosine-1-phosphate (S1P) metabolizing enzymes (SphK1, SphK2, SGPL1, SGPP1, SGPP2, PPAP2A, PPAP2B, and PPAP2C) by quantitative real-time polymerase chain reaction in tumor tissues and adjacent normal tissues of 50 oral squamous cell carcinoma (OSCC) patients. Expression of SphK1 and SGPP1 genes was up-regulated significantly in 70% and 75% OSCC tumors respectively. Importantly, expression of SphK2 and PPAP2B was down-regulated in the tumor tissues of 70% OSCC patients. Expression of SphK2 and PPAP2B negatively correlated with tumor-node-metastasis (TNM) staging and tumor volume respectively. Furthermore, LPP1 is an independent predictor of TNM staging and lymph node ratio.

Entities:  

Keywords:  Head and neck cancer; lipid phosphate phosphatase; miR-95-3p; sphingosine kinase 2; sphingosine-1-phosphate

Mesh:

Substances:

Year:  2017        PMID: 28135860     DOI: 10.1080/07357907.2016.1272695

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

1.  Prognostic roles of the expression of sphingosine-1-phosphate metabolism enzymes in non-small cell lung cancer.

Authors:  Yingqin Wang; Yaxing Shen; Xia Sun; Tinah L Hong; Long Shuang Huang; Ming Zhong
Journal:  Transl Lung Cancer Res       Date:  2019-10

2.  Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma.

Authors:  Jianing Xu; Yuanwei Zang; Shengda Cao; Dapeng Lei; Xinliang Pan
Journal:  Onco Targets Ther       Date:  2019-04-11       Impact factor: 4.147

Review 3.  Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.

Authors:  Yi-Ta Hsieh; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang; Wan-Chun Li
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

4.  Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma.

Authors:  Wenxiu Tian; Ping Wang; Zhimei Wang; Huimin Qi; Junhong Dong; Hongmei Wang
Journal:  Front Oncol       Date:  2021-11-30       Impact factor: 6.244

Review 5.  Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway.

Authors:  Eileen M McGowan; Yiguang Lin; Size Chen
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

6.  Downregulation of Lipid Phosphate Phosphatase 3 Correlates With Tumor-Infiltrating Immune Cells in Oral Cancer.

Authors:  Supriya Vishwakarma; Deepti Joshi; Ritu Pandey; Saikat Das; Sramana Mukhopadhyay; Renu Rai; Ritu Singhal; Neelkamal Kapoor; Ashok Kumar
Journal:  Cureus       Date:  2022-03-27

7.  Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells.

Authors:  Xin Zhang; Lan Zhang; Bihua Lin; Xingxing Chai; Ronggang Li; Yuehua Liao; Xinghui Deng; Qiongru Liu; Wenli Yang; Yubo Cai; Wei Zhou; Zhichao Lin; Wenhai Huang; Meigong Zhong; Fangyong Lei; Jinhua Wu; Shuaishuai Yu; Xiaoping Li; Shangren Li; Yueyue Li; Jincheng Zeng; Wansheng Long; Dong Ren; Yanming Huang
Journal:  Mol Cancer       Date:  2017-08-29       Impact factor: 27.401

Review 8.  S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling.

Authors:  Ashok Kumar; Jesus Zamora-Pineda; Emilie Degagné; Julie D Saba
Journal:  Mediators Inflamm       Date:  2017-12-03       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.